SEARCH:
Press Releases
Date
Title
Jan 06, 2012
ISTO Technologies, Inc., today announced that Scott Gill, Chief Financial Officer will be participating in a panel session at the Regenerative Medicine Insight Track at the Biotech Showcase being held January 9-11, 2012 in San Francisco.
Oct 13, 2011
St. Louis, MO, October 13, 2011 - ISTO Technologies, Inc., an orthobiologics company developing innovative cartilage and bone products for spinal therapy and sports medicine indications, today announced that it has received the Conformité Européenne (CE) Mark approval for its InQu® product line. InQu is a unique bone graft substitute and extender currently sold through a network of independent distributors in the United States. Receipt of the CE Mark enables ISTO to initiate a commercial launch of the product in Europe.
Feb 07, 2011
ISTO Technologies Awarded Key Patent for NuQu™ Injectable Therapy for Degenerative Disc Disease
Nov 29, 2010
ISTO Technologies, Inc., a privately-held orthobiologics company, announced today that Mitchell Seyedin, Ph. D., President and Chief Executive Officer, is scheduled to present at the 22nd Annual Piper Jaffray Health Care Conference in New York, NY.
Oct 05, 2010
ISTO Technologies Completes Enrollment in Phase I NuQu™ Clinical Trial - Novel Cell-Based Cartilage Regeneration for Treatment of Discogenic Back Pain
Jul 26, 2010
ISTO Technologies, Inc. announced today that it will participate in the BMO Capital Markets' 10th Annual Focus on Healthcare Conference to be held at the Sheraton New York Hotel & Towers in New York, NY on August 5,1 2010. Mitchell Seyedin, Ph. D., President and CEO, is scheduled to present a 30-minute overview of the company at 3:00 p.m. Eastern Time on Thursday, August 5th. The conference will feature presentations from over 90 public and private healthcare companies in the biotechnology, medical devices healthcare services and pharmaceutical areas.
May 12, 2010
ISTO Technologies announced today the publication of a scientific paper related to its cartilage technology in The American Journal of Sports Medicine.
Feb 26, 2010
ISTO Technologies, Inc. was recently selected to present at upcoming regenerative medicine event in Winston-Salem, NC.
Feb 16, 2010
ISTO Technologies, Inc. announced today that it will participate in the 2010 Canaccord Adams Musculoskeletal Conference to be held at the Sheraton New Orleans Hotel on Tuesday, March 9, 2010.
Apr 28, 2009
ISTO Technologies, Inc. announced today that it has received notification from the (FDA) allowing the company to proceed with a Phase I clinical study for NuQu™, an injectable therapy intended to regenerate the spinal disc nucleus.
RSS Feed